🌍·1d agodiscovery
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
Publisher
O
Ophthalmology Times
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Ophthalmology Times
- Region
- Global
- Scope
- discovery
- Published
- June 30, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: Ophthalmology Times
Scope: discovery
Related coverage
More related coverage
Seeking Alpha/6h ago
Medicare's GLP-1 Bridge and what's next for biotech (LLY:NYSE)
Fuel Cells Works/6h ago
Teva Launches Hydrogen Truck for Pharmaceutical Logistics
MedShadow Foundation/6h ago
FDA Recalls and Warnings: Foreign Substance Found in Millions of Prednisolone Bottles, Seizure Drug Mix-Up & More
Pharmaceutical Technology/6h ago